PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-17

Date Title Company
17-Jan-2026 Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque Businesswire